en · de · es · fr · pt
analytical-notes.peptides9002.com › Faq › Melanotan-2 Identity And Regulatory Status — Hands-On Walkthrough

Melanotan-2 Identity And Regulatory Status — Hands-On Walkthrough

By Editorial Desk · published 2026-03-29 · last reviewed 2026-04-22 · Faq

The short version of Alpha-MSH fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2026-04-22 and is reviewed periodically as new material appears.

Melanotan-2 Identity And Regulatory Status

Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.

Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.

Melanotan II Background and Mechanism

Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.

Receptor binding at MC1R on melanocytes raises intracellular cyclic AMP and increases expression of tyrosinase and related enzymes. The downstream result is greater synthesis of eumelanin, the dark pigment, without ultraviolet exposure acting as the trigger. The compound is not selective, however, and also engages MC3R, MC4R and MC5R, which are expressed in the central nervous system and elsewhere. That lack of selectivity is the explanation usually offered for effects reported outside pigmentation, including appetite suppression and nausea. Selectivity remains a central theme in comparative studies of related peptides.

Human data remain limited and mostly short-term. Reports describe small trials and observational accounts rather than large controlled studies, so questions about dose-response relationships and long-term effects on melanocytes stay open. Whether repeated exposure alters naevus behaviour is not settled in the published record. Researchers also note that self-administered use outside clinical settings makes actual exposure difficult to quantify. Statements about efficacy and safety should therefore be read as preliminary rather than established.

Melanotan-2 at a glance

PropertyValueNotes
Chemical classSynthetic cyclic heptapeptideAnalogue of alpha-melanocyte-stimulating hormone
Common synonymsMT-II; melanotan 2No internationally accepted non-proprietary name
Typical presentationLyophilised powder in a sealed vialOften supplied alongside a separate diluent
Regulatory statusUnapproved therapeutic substanceCustoms seizure reported in several jurisdictions
Reported route in useSubcutaneous injectionSelf-administered outside clinical settings

Notes from published material

A special form of clubbing is hypertrophic pulmonary osteoarthropathy (HPOA), known in continental Europe as Pierre Marie-Bamberger syndrome. This is the combination of clubbing and thickening of periosteum (connective tissue lining of the bones) and synovium (lining of joints), and is often initially diagnosed as arthritis. It is commonly associated with lung cancer.

The black desert cobra (Walterinnesia aegyptia) is a highly venomous snake species found in the Middle East. The subcutaneous LD50 for the venom of this species is 0.40 mg/kg. For comparison, the Indian cobra's (naja naja) subcutaneous LD50 is 0.80 mg/kg, while the Cape cobra's (naja nivea) subcutaneous LD50 is 0.72 mg/kg. This makes the black desert cobra a more venomous species than both. The venom is strongly neurotoxic and also has mild hemotoxic factors. Envenomation usually causes some combination of local pain, swelling, fever, general weakness, headache, & vomiting. This is not a typically aggressive snake, but it will strike and hiss loudly when provoked. It can strike at a distance of two-thirds of its body length. It does not usually spread a hood nor hold up its body up off the ground like true cobras do. Envenomation by this species should be considered a serious medical emergency. Human fatalities due to envenomation by this species have been reported.

However, much of the white community saw Whitehead as too radical, and soft on what they saw as black extremism. As a result, the UFP was soundly defeated in the primarily white seats by the Rhodesian Front (RF), a newly formed alliance of conservative voices headed by Winston Field and Ian Smith, in what was widely considered a shock result. Field became Prime Minister, with Smith as his deputy.

Sources: en.wikipedia.org

Related pages on this site

Further detail

==== Colombia ==== Caldo de raíz (lit. 'root soup') or caldo peligroso (lit. 'dangerous broth') is a Colombian cuisine bull penis and testicles soup. The soup is cooked for hours with potatoes, peas, and occasionally beans. Caldo de raíz is eaten as an aphrodisiac.

I reject only the concept that black liberation can be achieved through the leadership of white liberals." He added that "the [white] liberal is no enemy, he's a friend – but for the moment he holds us back, offering a formula too gentle, too inadequate for our struggle". Biko's approach to activism focused on psychological empowerment, and both he and the BCM saw their main purpose as combating the feeling of inferiority that most black South Africans experienced. Biko expressed dismay at how "the black man has become a shell, a shadow of man ... bearing the yoke of oppression with sheepish timidity", and stated that "the most potent weapon in the hands of the oppressor is the mind of the oppressed". He believed that blacks needed to affirm their own humanity by overcoming their fears and believing themselves worthy of freedom and its attendant responsibilities. He defined Black Consciousness as "an inward-looking process" that would "infuse people with pride and dignity". To promote this, the BCM adopted the slogan "Black is Beautiful". One of the ways that Biko and the BCM sought to achieve psychological empowerment was through community development. Community projects were seen not only as a way to alleviate poverty in black communities but also as a means of transforming society psychologically, culturally, and economically. They would also help students to learn about the "daily struggles" of ordinary black people and to spread Black Consciousness ideas among the population.

=== TNF inhibitors === Tumor necrosis factor inhibitors (TNFi) are a class of biologic drugs used in the treatment of ankylosing spondylitis. TNFi drugs, such as etanercept, infliximab, adalimumab, certolizumab, and golimumab, target the inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha). TNF-alpha plays a key role in the inflammatory process in ankylosing spondylitis. By blocking TNF-alpha, TNFi drugs help reduce inflammation, pain, and stiffness associated with AS, and may also slow down the progression of spinal damage.

Sources: en.wikipedia.org

Frequently asked questions

Is melanotan II approved for medical use?

No. No major regulatory agency has granted a marketing authorisation for melanotan II as a medicine. Products sold under this name are generally presented as laboratory reagents and are not subject to the batch-release testing applied to approved drugs.

Where did melanotan II originate?

It was developed in the 1980s by researchers investigating analogues of alpha-melanocyte-stimulating hormone for pigmentation and related endpoints. Early work included small human studies during the 1990s. Development did not progress to licensing, and the compound remained a research and grey-market item.

Why is purity a concern for unapproved peptides?

Peptides are prone to truncation, oxidation and aggregation during synthesis and handling. Without independent testing, a buyer cannot confirm the identity or the content of a vial. Analytical surveys of unapproved peptide products have repeatedly found discrepancies between label claims and measured composition.

What class of compound is melanotan II?

It is a synthetic cyclic heptapeptide and a non-selective melanocortin receptor agonist. Structurally it is modelled on alpha-melanocyte-stimulating hormone, a peptide that occurs naturally in the body.

Network